Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocytes, Cardiac | 20 | 2024 | 622 | 4.430 |
Why?
|
Heart | 11 | 2023 | 717 | 2.370 |
Why?
|
Myocardium | 12 | 2023 | 996 | 2.250 |
Why?
|
Human Embryonic Stem Cells | 4 | 2022 | 23 | 2.160 |
Why?
|
Cellular Reprogramming | 3 | 2023 | 116 | 2.120 |
Why?
|
Myocardial Infarction | 9 | 2023 | 1011 | 1.790 |
Why?
|
Pluripotent Stem Cells | 6 | 2021 | 75 | 1.620 |
Why?
|
Pericytes | 2 | 2023 | 23 | 1.610 |
Why?
|
Stem Cell Transplantation | 5 | 2023 | 236 | 1.530 |
Why?
|
Cell Differentiation | 17 | 2022 | 1930 | 1.520 |
Why?
|
Embryonic Stem Cells | 6 | 2018 | 170 | 1.420 |
Why?
|
Cell Lineage | 7 | 2021 | 348 | 1.200 |
Why?
|
Regeneration | 5 | 2023 | 203 | 1.170 |
Why?
|
Regenerative Medicine | 3 | 2023 | 30 | 1.010 |
Why?
|
Coronary Aneurysm | 2 | 2018 | 34 | 0.840 |
Why?
|
Fibroblasts | 5 | 2023 | 890 | 0.820 |
Why?
|
Cell Separation | 2 | 2021 | 229 | 0.780 |
Why?
|
Heart Diseases | 2 | 2023 | 485 | 0.760 |
Why?
|
Heart Injuries | 2 | 2018 | 46 | 0.730 |
Why?
|
Cell Proliferation | 9 | 2023 | 2304 | 0.720 |
Why?
|
Integrases | 2 | 2019 | 161 | 0.720 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2022 | 195 | 0.700 |
Why?
|
Animals | 35 | 2024 | 34149 | 0.700 |
Why?
|
Mesoderm | 3 | 2016 | 113 | 0.690 |
Why?
|
Mice | 21 | 2023 | 17729 | 0.680 |
Why?
|
Biocompatible Materials | 6 | 2022 | 123 | 0.680 |
Why?
|
Antigens, Differentiation | 2 | 2017 | 63 | 0.670 |
Why?
|
Recombination, Genetic | 2 | 2019 | 448 | 0.670 |
Why?
|
Myoblasts, Cardiac | 2 | 2018 | 7 | 0.660 |
Why?
|
Fibrosis | 5 | 2023 | 433 | 0.660 |
Why?
|
Genes, Reporter | 1 | 2021 | 383 | 0.660 |
Why?
|
Aortic Valve Stenosis | 2 | 2014 | 337 | 0.640 |
Why?
|
Coronary Vessels | 4 | 2018 | 537 | 0.630 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2018 | 3 | 0.620 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 2 | 2016 | 36 | 0.600 |
Why?
|
Cardiovascular Diseases | 6 | 2023 | 1890 | 0.600 |
Why?
|
Non-ST Elevated Myocardial Infarction | 1 | 2018 | 14 | 0.580 |
Why?
|
Transcriptome | 2 | 2021 | 937 | 0.580 |
Why?
|
Homeobox Protein Nkx-2.5 | 1 | 2017 | 16 | 0.570 |
Why?
|
Coronary Artery Bypass | 3 | 2018 | 511 | 0.570 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2018 | 73 | 0.560 |
Why?
|
Endothelial Cells | 6 | 2022 | 524 | 0.550 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 353 | 0.530 |
Why?
|
Gene Targeting | 1 | 2017 | 179 | 0.530 |
Why?
|
Nanoparticles | 1 | 2019 | 233 | 0.530 |
Why?
|
Genetic Engineering | 1 | 2017 | 163 | 0.520 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2018 | 171 | 0.520 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2020 | 122 | 0.520 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2018 | 152 | 0.520 |
Why?
|
CD13 Antigens | 1 | 2016 | 15 | 0.520 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 209 | 0.510 |
Why?
|
Cell Tracking | 1 | 2015 | 16 | 0.510 |
Why?
|
Ferrosoferric Oxide | 1 | 2015 | 26 | 0.490 |
Why?
|
Bacterial Adhesion | 3 | 2003 | 108 | 0.490 |
Why?
|
Heart Failure | 3 | 2023 | 2155 | 0.460 |
Why?
|
Arteriosclerosis | 1 | 2014 | 142 | 0.450 |
Why?
|
Parabiosis | 1 | 2013 | 3 | 0.440 |
Why?
|
Cardiomyopathies | 1 | 2018 | 479 | 0.440 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2015 | 159 | 0.440 |
Why?
|
Coronary Stenosis | 1 | 2014 | 73 | 0.440 |
Why?
|
Humans | 50 | 2023 | 124307 | 0.430 |
Why?
|
Apoproteins | 2 | 2003 | 20 | 0.420 |
Why?
|
Transferrin | 2 | 2003 | 51 | 0.410 |
Why?
|
Macrophages | 3 | 2022 | 618 | 0.410 |
Why?
|
Staphylococcus epidermidis | 2 | 2003 | 41 | 0.410 |
Why?
|
Mice, Transgenic | 6 | 2023 | 2408 | 0.410 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 578 | 0.410 |
Why?
|
Arrhythmias, Cardiac | 2 | 2015 | 462 | 0.380 |
Why?
|
Genetic Variation | 1 | 2018 | 1492 | 0.380 |
Why?
|
Aortic Valve | 1 | 2014 | 442 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 173 | 0.340 |
Why?
|
Aortic Diseases | 1 | 2012 | 198 | 0.330 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2017 | 160 | 0.330 |
Why?
|
Fetus | 1 | 2013 | 584 | 0.320 |
Why?
|
Tissue Engineering | 2 | 2022 | 174 | 0.320 |
Why?
|
Heart Transplantation | 3 | 2020 | 858 | 0.310 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 675 | 0.310 |
Why?
|
DNA Methylation | 3 | 2023 | 1004 | 0.290 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2012 | 723 | 0.280 |
Why?
|
Leiomyosarcoma | 1 | 2006 | 28 | 0.270 |
Why?
|
Cells, Cultured | 6 | 2024 | 3052 | 0.270 |
Why?
|
Polyurethanes | 2 | 2003 | 18 | 0.270 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2006 | 66 | 0.260 |
Why?
|
Coronary Angiography | 4 | 2018 | 426 | 0.250 |
Why?
|
Pericardium | 2 | 2018 | 82 | 0.250 |
Why?
|
Heart Neoplasms | 1 | 2006 | 102 | 0.250 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 368 | 0.250 |
Why?
|
MicroRNAs | 2 | 2023 | 840 | 0.250 |
Why?
|
Uterine Neoplasms | 1 | 2006 | 107 | 0.250 |
Why?
|
Mammals | 2 | 2023 | 260 | 0.250 |
Why?
|
Graft Rejection | 2 | 2020 | 590 | 0.250 |
Why?
|
Atherosclerosis | 1 | 2012 | 841 | 0.230 |
Why?
|
Transgenes | 2 | 2017 | 337 | 0.230 |
Why?
|
Animals, Newborn | 3 | 2018 | 1008 | 0.230 |
Why?
|
Zebrafish | 2 | 2018 | 388 | 0.230 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 579 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 3575 | 0.230 |
Why?
|
Female | 20 | 2022 | 66235 | 0.220 |
Why?
|
Coronary Artery Disease | 2 | 2008 | 754 | 0.220 |
Why?
|
Cell Culture Techniques | 3 | 2020 | 288 | 0.210 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2006 | 360 | 0.210 |
Why?
|
Cell Transdifferentiation | 1 | 2023 | 66 | 0.210 |
Why?
|
Electric Conductivity | 2 | 2022 | 89 | 0.210 |
Why?
|
Green Fluorescent Proteins | 2 | 2014 | 392 | 0.200 |
Why?
|
Stem Cells | 2 | 2020 | 701 | 0.200 |
Why?
|
Nanotubes, Carbon | 1 | 2022 | 19 | 0.200 |
Why?
|
Ventricular Remodeling | 1 | 2023 | 174 | 0.200 |
Why?
|
RNA Splicing | 1 | 2023 | 226 | 0.200 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2008 | 174 | 0.200 |
Why?
|
Tomography, X-Ray Computed | 2 | 2007 | 2089 | 0.200 |
Why?
|
Trophoblasts | 2 | 2013 | 114 | 0.190 |
Why?
|
Extracellular Matrix | 1 | 2023 | 231 | 0.190 |
Why?
|
Tunica Intima | 1 | 2022 | 59 | 0.190 |
Why?
|
Cell Line | 4 | 2016 | 2772 | 0.190 |
Why?
|
Thrombin | 1 | 2022 | 59 | 0.190 |
Why?
|
Fibrin | 1 | 2022 | 66 | 0.190 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 337 | 0.190 |
Why?
|
Male | 17 | 2021 | 60967 | 0.180 |
Why?
|
Antibodies | 2 | 2020 | 371 | 0.180 |
Why?
|
Disease Models, Animal | 3 | 2022 | 4356 | 0.180 |
Why?
|
Signal Transduction | 4 | 2023 | 4536 | 0.180 |
Why?
|
Pseudomonas aeruginosa | 1 | 2002 | 167 | 0.180 |
Why?
|
Clone Cells | 1 | 2021 | 167 | 0.180 |
Why?
|
Extracellular Vesicles | 1 | 2021 | 46 | 0.170 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 224 | 0.170 |
Why?
|
Collagen | 1 | 2021 | 314 | 0.170 |
Why?
|
Thrombosis | 2 | 2022 | 519 | 0.160 |
Why?
|
Endothelium, Vascular | 2 | 2013 | 515 | 0.160 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 1696 | 0.160 |
Why?
|
Environmental Exposure | 1 | 2021 | 222 | 0.160 |
Why?
|
Nanostructures | 1 | 2019 | 52 | 0.160 |
Why?
|
Action Potentials | 1 | 2022 | 501 | 0.160 |
Why?
|
Aorta | 2 | 2022 | 537 | 0.150 |
Why?
|
Mice, Inbred C3H | 1 | 2018 | 118 | 0.150 |
Why?
|
Staphylococcus aureus | 1 | 2002 | 459 | 0.150 |
Why?
|
Intravital Microscopy | 1 | 2018 | 17 | 0.150 |
Why?
|
Phenotype | 2 | 2018 | 4256 | 0.150 |
Why?
|
Outpatients | 1 | 2020 | 253 | 0.150 |
Why?
|
Isoproterenol | 1 | 2018 | 105 | 0.150 |
Why?
|
Renin-Angiotensin System | 1 | 2019 | 96 | 0.150 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 375 | 0.150 |
Why?
|
Comorbidity | 2 | 2014 | 1515 | 0.150 |
Why?
|
Intraoperative Period | 1 | 2018 | 75 | 0.150 |
Why?
|
Wound Healing | 1 | 2022 | 458 | 0.150 |
Why?
|
Fluorescent Antibody Technique | 2 | 2016 | 459 | 0.150 |
Why?
|
Respiratory System | 1 | 2018 | 95 | 0.150 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 185 | 0.150 |
Why?
|
Echocardiography | 3 | 2021 | 1052 | 0.140 |
Why?
|
Hematopoietic Stem Cells | 1 | 2022 | 543 | 0.140 |
Why?
|
Antineoplastic Agents, Immunological | 1 | 2019 | 109 | 0.140 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2018 | 73 | 0.140 |
Why?
|
Species Specificity | 1 | 2018 | 549 | 0.140 |
Why?
|
Social Norms | 1 | 2017 | 6 | 0.140 |
Why?
|
Investments | 1 | 2017 | 12 | 0.140 |
Why?
|
Tamoxifen | 1 | 2019 | 363 | 0.140 |
Why?
|
Mice, Inbred C57BL | 4 | 2022 | 4425 | 0.140 |
Why?
|
Microscopy, Fluorescence | 4 | 2021 | 328 | 0.140 |
Why?
|
Disease Progression | 2 | 2014 | 2039 | 0.140 |
Why?
|
Angiography | 1 | 2018 | 217 | 0.140 |
Why?
|
Gene Silencing | 2 | 2016 | 238 | 0.140 |
Why?
|
Fetal Heart | 1 | 2018 | 117 | 0.140 |
Why?
|
Heart Ventricles | 1 | 2022 | 769 | 0.140 |
Why?
|
Luminescent Proteins | 1 | 2017 | 158 | 0.140 |
Why?
|
Lung Neoplasms | 1 | 2006 | 1598 | 0.140 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 63 | 0.140 |
Why?
|
Monocytes | 1 | 2019 | 352 | 0.140 |
Why?
|
Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
|
Aging | 3 | 2023 | 1185 | 0.130 |
Why?
|
Risk Assessment | 4 | 2019 | 3382 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 1288 | 0.130 |
Why?
|
Cell Division | 2 | 2014 | 781 | 0.120 |
Why?
|
Ferric Compounds | 1 | 2015 | 37 | 0.120 |
Why?
|
Muscle, Smooth | 1 | 2016 | 135 | 0.120 |
Why?
|
Transplantation, Heterologous | 1 | 2016 | 253 | 0.120 |
Why?
|
Heterografts | 1 | 2015 | 177 | 0.120 |
Why?
|
American Heart Association | 1 | 2017 | 299 | 0.120 |
Why?
|
Severity of Illness Index | 2 | 2014 | 2888 | 0.120 |
Why?
|
Precision Medicine | 1 | 2018 | 315 | 0.120 |
Why?
|
Coronavirus Infections | 1 | 2020 | 358 | 0.120 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 374 | 0.120 |
Why?
|
Adult | 7 | 2023 | 29385 | 0.110 |
Why?
|
Advisory Committees | 1 | 2015 | 150 | 0.110 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 63 | 0.110 |
Why?
|
Antigens, CD34 | 1 | 2014 | 108 | 0.110 |
Why?
|
Biopsy | 1 | 2018 | 1237 | 0.110 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 645 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 28 | 0.110 |
Why?
|
Polymers | 3 | 2022 | 108 | 0.110 |
Why?
|
Receptors, Immunologic | 1 | 2014 | 109 | 0.110 |
Why?
|
Sex Distribution | 1 | 2014 | 297 | 0.110 |
Why?
|
DNA | 1 | 2019 | 1600 | 0.110 |
Why?
|
Transcription Factors | 1 | 2023 | 2608 | 0.110 |
Why?
|
Ear, Inner | 1 | 2013 | 51 | 0.110 |
Why?
|
Age Distribution | 1 | 2014 | 413 | 0.110 |
Why?
|
Maternal-Fetal Exchange | 1 | 2013 | 81 | 0.110 |
Why?
|
Primitive Streak | 1 | 2013 | 2 | 0.110 |
Why?
|
Radiography | 1 | 2015 | 827 | 0.110 |
Why?
|
Tissue Survival | 1 | 2013 | 8 | 0.110 |
Why?
|
Indium Radioisotopes | 1 | 1993 | 10 | 0.110 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 241 | 0.110 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2013 | 24 | 0.110 |
Why?
|
Multipotent Stem Cells | 1 | 2013 | 29 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 65 | 0.100 |
Why?
|
Cardiovascular System | 1 | 2014 | 102 | 0.100 |
Why?
|
Survival Analysis | 2 | 2014 | 1482 | 0.100 |
Why?
|
Flow Cytometry | 4 | 2021 | 802 | 0.100 |
Why?
|
Endoderm | 1 | 2012 | 25 | 0.100 |
Why?
|
Mosaicism | 1 | 2014 | 241 | 0.100 |
Why?
|
Swine | 1 | 2016 | 1173 | 0.100 |
Why?
|
Heart-Assist Devices | 1 | 2021 | 1046 | 0.100 |
Why?
|
Stage-Specific Embryonic Antigens | 1 | 2011 | 2 | 0.100 |
Why?
|
Biomarkers | 4 | 2013 | 2971 | 0.090 |
Why?
|
Middle Aged | 7 | 2020 | 26452 | 0.090 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 112 | 0.090 |
Why?
|
Fetal Growth Retardation | 1 | 2013 | 240 | 0.090 |
Why?
|
Cattle | 2 | 2003 | 563 | 0.090 |
Why?
|
Biomedical Research | 1 | 2017 | 518 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2013 | 1000 | 0.090 |
Why?
|
Genetic Testing | 1 | 2018 | 1004 | 0.090 |
Why?
|
Genes, bcl-2 | 1 | 2011 | 10 | 0.090 |
Why?
|
Pregnancy | 3 | 2022 | 7168 | 0.090 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2011 | 54 | 0.090 |
Why?
|
Wnt Proteins | 1 | 2012 | 195 | 0.090 |
Why?
|
Serum | 1 | 2011 | 47 | 0.090 |
Why?
|
Secondary Prevention | 1 | 2012 | 215 | 0.090 |
Why?
|
Polysaccharides | 1 | 2011 | 142 | 0.090 |
Why?
|
Teratoma | 1 | 2011 | 123 | 0.090 |
Why?
|
Cardiology | 1 | 2015 | 478 | 0.080 |
Why?
|
Brain | 1 | 2021 | 3002 | 0.080 |
Why?
|
Placenta | 1 | 2013 | 506 | 0.080 |
Why?
|
Prognosis | 2 | 2019 | 4549 | 0.080 |
Why?
|
Alleles | 1 | 2014 | 1615 | 0.080 |
Why?
|
Algorithms | 1 | 2016 | 1610 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2011 | 256 | 0.080 |
Why?
|
Cell Survival | 1 | 2011 | 805 | 0.080 |
Why?
|
Postoperative Complications | 1 | 2020 | 3069 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2020 | 12292 | 0.070 |
Why?
|
Hemodynamics | 1 | 2012 | 844 | 0.070 |
Why?
|
Prevalence | 1 | 2014 | 2429 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 3137 | 0.070 |
Why?
|
Chronic Disease | 1 | 2012 | 1185 | 0.070 |
Why?
|
Time Factors | 2 | 2016 | 6272 | 0.070 |
Why?
|
Embolism, Paradoxical | 1 | 2006 | 4 | 0.070 |
Why?
|
Embolectomy | 1 | 2006 | 9 | 0.070 |
Why?
|
Coronary Restenosis | 1 | 2006 | 20 | 0.070 |
Why?
|
Coated Materials, Biocompatible | 1 | 2006 | 42 | 0.070 |
Why?
|
Ticlopidine | 1 | 2006 | 28 | 0.070 |
Why?
|
Models, Animal | 2 | 2018 | 465 | 0.070 |
Why?
|
Systole | 1 | 2006 | 195 | 0.060 |
Why?
|
Drug Resistance, Multiple | 1 | 2006 | 49 | 0.060 |
Why?
|
Cardiovascular Agents | 1 | 2006 | 86 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 1016 | 0.060 |
Why?
|
Aged | 5 | 2020 | 19481 | 0.060 |
Why?
|
Calcinosis | 1 | 2006 | 174 | 0.060 |
Why?
|
Positron-Emission Tomography | 1 | 2006 | 298 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2021 | 16228 | 0.060 |
Why?
|
Neoplasms | 1 | 2019 | 2761 | 0.060 |
Why?
|
Aspirin | 1 | 2006 | 222 | 0.060 |
Why?
|
Mutation | 1 | 2018 | 5806 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2006 | 261 | 0.060 |
Why?
|
Biosensing Techniques | 1 | 2024 | 53 | 0.060 |
Why?
|
Young Adult | 1 | 2018 | 8974 | 0.060 |
Why?
|
Coronary Disease | 1 | 2007 | 652 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2007 | 560 | 0.050 |
Why?
|
Immunoelectrophoresis | 1 | 2003 | 12 | 0.050 |
Why?
|
Prospective Studies | 1 | 2014 | 6071 | 0.050 |
Why?
|
Depression, Chemical | 1 | 2003 | 44 | 0.050 |
Why?
|
Chromatography, Ion Exchange | 1 | 2003 | 68 | 0.050 |
Why?
|
RNA Splicing Factors | 1 | 2023 | 50 | 0.050 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2004 | 200 | 0.050 |
Why?
|
Heart Valve Diseases | 1 | 2004 | 168 | 0.050 |
Why?
|
United States | 2 | 2017 | 10766 | 0.050 |
Why?
|
Video Recording | 1 | 2024 | 183 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2020 | 5105 | 0.050 |
Why?
|
Recurrence | 1 | 2006 | 1422 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 1103 | 0.050 |
Why?
|
Polystyrenes | 1 | 2002 | 13 | 0.050 |
Why?
|
Mesonephros | 1 | 2022 | 2 | 0.050 |
Why?
|
Polymethyl Methacrylate | 1 | 2002 | 24 | 0.050 |
Why?
|
Cardiac Catheterization | 1 | 2006 | 632 | 0.050 |
Why?
|
Silicones | 1 | 2002 | 38 | 0.050 |
Why?
|
Calcium | 1 | 2007 | 1095 | 0.050 |
Why?
|
Equipment Design | 1 | 2024 | 597 | 0.050 |
Why?
|
Longevity | 1 | 2023 | 140 | 0.050 |
Why?
|
Endothelium | 1 | 2022 | 72 | 0.050 |
Why?
|
Wnt Signaling Pathway | 1 | 2023 | 196 | 0.050 |
Why?
|
Hydrogels | 1 | 2022 | 84 | 0.050 |
Why?
|
Blotting, Southern | 1 | 2021 | 215 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2023 | 350 | 0.050 |
Why?
|
Regional Blood Flow | 1 | 2022 | 209 | 0.050 |
Why?
|
Ductus Arteriosus | 1 | 2022 | 63 | 0.050 |
Why?
|
Phylogeny | 1 | 2023 | 696 | 0.050 |
Why?
|
Prosthesis-Related Infections | 1 | 2003 | 179 | 0.050 |
Why?
|
Immunity | 1 | 2022 | 191 | 0.040 |
Why?
|
Primates | 1 | 2021 | 80 | 0.040 |
Why?
|
Los Angeles | 1 | 2020 | 17 | 0.040 |
Why?
|
In Vitro Techniques | 1 | 2002 | 969 | 0.040 |
Why?
|
Pyrroles | 1 | 2022 | 179 | 0.040 |
Why?
|
Genome | 1 | 2023 | 476 | 0.040 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2013 | 510 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2020 | 54 | 0.040 |
Why?
|
Hematopoiesis | 1 | 2022 | 219 | 0.040 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2004 | 438 | 0.040 |
Why?
|
Stents | 1 | 2006 | 885 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 1236 | 0.040 |
Why?
|
Allografts | 1 | 2020 | 192 | 0.040 |
Why?
|
Cardiotoxicity | 1 | 2019 | 24 | 0.040 |
Why?
|
Gold | 1 | 2019 | 49 | 0.040 |
Why?
|
Cell Cycle | 1 | 2021 | 616 | 0.040 |
Why?
|
Infection Control | 1 | 2020 | 159 | 0.040 |
Why?
|
HLA Antigens | 1 | 2020 | 243 | 0.040 |
Why?
|
Vasculitis | 1 | 2019 | 49 | 0.040 |
Why?
|
Carbon | 1 | 2019 | 92 | 0.040 |
Why?
|
Pericarditis | 1 | 2019 | 42 | 0.040 |
Why?
|
Activating Transcription Factor 3 | 1 | 2018 | 5 | 0.040 |
Why?
|
Time-Lapse Imaging | 1 | 2018 | 9 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 411 | 0.040 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2018 | 24 | 0.040 |
Why?
|
Rodentia | 1 | 2018 | 46 | 0.040 |
Why?
|
Perioperative Care | 1 | 2020 | 196 | 0.040 |
Why?
|
Embryo, Nonmammalian | 1 | 2018 | 144 | 0.040 |
Why?
|
Angina Pectoris | 2 | 2008 | 59 | 0.040 |
Why?
|
Myocarditis | 1 | 2019 | 119 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 1 | 2006 | 1111 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2012 | 1685 | 0.040 |
Why?
|
Light | 1 | 2018 | 177 | 0.040 |
Why?
|
Morphogenesis | 1 | 2018 | 212 | 0.040 |
Why?
|
Rats | 1 | 2024 | 3686 | 0.040 |
Why?
|
Risk Factors | 3 | 2019 | 10141 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2018 | 180 | 0.030 |
Why?
|
Tretinoin | 1 | 2016 | 116 | 0.030 |
Why?
|
Kinetics | 1 | 2018 | 1321 | 0.030 |
Why?
|
Genetic Markers | 1 | 2018 | 606 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 2535 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 356 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 764 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2016 | 315 | 0.030 |
Why?
|
Cross Circulation | 1 | 2014 | 5 | 0.030 |
Why?
|
Receptor, TIE-2 | 1 | 2014 | 13 | 0.030 |
Why?
|
PAX3 Transcription Factor | 1 | 2014 | 27 | 0.030 |
Why?
|
Doxorubicin | 1 | 2016 | 297 | 0.030 |
Why?
|
Paired Box Transcription Factors | 1 | 2014 | 75 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2021 | 2867 | 0.030 |
Why?
|
Reoperation | 2 | 2008 | 831 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2014 | 121 | 0.030 |
Why?
|
Sulfur Radioisotopes | 1 | 1993 | 9 | 0.030 |
Why?
|
Oxyquinoline | 1 | 1993 | 5 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2008 | 1099 | 0.030 |
Why?
|
Bacterial Physiological Phenomena | 1 | 1993 | 17 | 0.030 |
Why?
|
Isotope Labeling | 1 | 1993 | 105 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2014 | 261 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1993 | 153 | 0.030 |
Why?
|
Glutamyl Aminopeptidase | 1 | 2012 | 3 | 0.030 |
Why?
|
Methionine | 1 | 1993 | 103 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 1993 | 395 | 0.030 |
Why?
|
Antigens, CD | 1 | 2014 | 421 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2012 | 59 | 0.020 |
Why?
|
Antigens, Surface | 1 | 2012 | 121 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 399 | 0.020 |
Why?
|
Societies, Medical | 1 | 2015 | 683 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 230 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1017 | 0.020 |
Why?
|
Stroke | 2 | 2008 | 974 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 515 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2018 | 1698 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 1006 | 0.020 |
Why?
|
Bacteria | 1 | 1993 | 485 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2008 | 86 | 0.020 |
Why?
|
Clinical Competence | 1 | 2015 | 996 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2013 | 2824 | 0.020 |
Why?
|
Computational Biology | 1 | 2011 | 820 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2008 | 307 | 0.020 |
Why?
|
Liver | 1 | 2013 | 1761 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2006 | 114 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 2006 | 121 | 0.020 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2006 | 121 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2006 | 193 | 0.010 |
Why?
|
Pacemaker, Artificial | 1 | 2006 | 176 | 0.010 |
Why?
|
History, 21st Century | 1 | 2004 | 269 | 0.010 |
Why?
|
Forecasting | 1 | 2004 | 350 | 0.010 |
Why?
|
History, 20th Century | 1 | 2004 | 384 | 0.010 |
Why?
|
Length of Stay | 1 | 2008 | 1308 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2006 | 1244 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 2020 | 0.010 |
Why?
|
Anticoagulants | 1 | 2006 | 585 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2004 | 687 | 0.010 |
Why?
|
Heart Valve Prosthesis | 1 | 2004 | 300 | 0.010 |
Why?
|
Electrocardiography | 1 | 2006 | 966 | 0.010 |
Why?
|
Cohort Studies | 1 | 2007 | 4731 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2006 | 815 | 0.010 |
Why?
|